Outcome Capital

Outcome Capital company information, Employees & Contact Information

Explore related pages

Related company profiles:

Outcome Capital is a highly specialized life sciences and healthcare advisory and investment banking firm, providing innovative companies with a value-added, market-aligned approach to mergers & acquisitions, partnering and corporate finance. The firm leverages its proven ‘strategy-led execution’ approach to value enhancement by assisting management teams and their boards in navigating both financial and corporate markets and implementing the best path for success. The firm’s strength stems from its multi-disciplinary, industry experts who draw from their broad relationships and a wide range of scientific, operational, strategic and transactional expertise across the value chain. Comprised of former CEOs, business development executives, venture capitalists, PhD/MD-level scientists and clinicians, and experienced commercialization experts, our team is driven to propel innovation from bench to bedside. Outcome Capital is proud of its unique culture of intellectual agility and openness, data-driven perspectives, strategic thinking, and commitment to teamwork. We are devoted to providing unmatched advisory services to our clients and share an uncompromised dedication to the life sciences and healthcare industry success. The Outcome Capital Difference - - Creating Extraordinary Outcomes. Maximizing your company’s value by bringing… - Unique Insights - In-depth Industry Experience & Networks - Personal Commitment to Clients - Exceptional Record of Success Outcome provides comprehensive strategic advisory and investment banking services in the following areas: Life Sciences - Pharma - Medical Devices - Biotech - Healthcare Services - Diagnostics - Tools and Research - Pharma services - Digital health
Looking for a particular Outcome Capital employee's phone or email?

Outcome Capital Questions

News

Outcome Capital Launches the First Dedicated Ophthalmology Practice to Address the World’s Leading Cause of Disability - Business Wire

Outcome Capital Launches the First Dedicated Ophthalmology Practice to Address the World’s Leading Cause of Disability Business Wire

Outcome Capital Announces Partnership of ZIEN Medical and Averra Holdings - Business Wire

Outcome Capital Announces Partnership of ZIEN Medical and Averra Holdings Business Wire

Outcome Capital Congratulates RealizedCare on the Acquisition by XRHealth - Business Wire

Outcome Capital Congratulates RealizedCare on the Acquisition by XRHealth Business Wire

Astellas Pharma Acquires Propella Therapeutics - citybiz

Astellas Pharma Acquires Propella Therapeutics citybiz

Paul Ryb to lead dedicated ophthalmology practice at Outcome Capital - LaingBuisson News

Paul Ryb to lead dedicated ophthalmology practice at Outcome Capital LaingBuisson News

Outcome Capital Continues to Expand with the Addition of Charles Simmons - Business Wire

Outcome Capital Continues to Expand with the Addition of Charles Simmons Business Wire

Outcome Capital and YAFO Capital Announce Strategic Partnership to Expand Global Strategic and Financial Services to Biopharma and Healthcare Clients - Business Wire

Outcome Capital and YAFO Capital Announce Strategic Partnership to Expand Global Strategic and Financial Services to Biopharma and Healthcare Clients Business Wire

Top Outcome Capital Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant